Journal of Medicinal Chemistry, 0022-2623

Journal

  1. 2019
  2. Krieger, V., Hamacher, A., Cao, F., Stenzel, K., Gertzen, C. G. W., Schäker-Hübner, L., ... Hansen, F. K. (2019). Synthesis of peptoid-based class I selective histone deacetylase inhibitors with chemosensitizing properties. Journal of Medicinal Chemistry, 62(24), 11260-11279. https://doi.org/10.1021/acs.jmedchem.9b01489
  3. 2018
  4. 2017
  5. Twarda-Clapa, A., Krzanik, S., Kubica, K., Guzik, K., Labuzek, B., Neochoritis, C. G., ... Holak, T. A. (2017). 1,4,5-Trisubstituted Imidazole-Based p53-MDM2/MDMX Antagonists with Aliphatic Linkers for Conjugation with Biological Carriers. Journal of Medicinal Chemistry, 60(10), 4234-4244. https://doi.org/10.1021/acs.jmedchem.7b00104
  6. 2016
  7. Pretze, M., Pallavi, P., Roscher, M., Klotz, S., Caballero, J., Binzen, U., ... Wängler, B. (2016). Radiofluorinated N-Octanoyl Dopamine ([F-18]F-NOD) as a Tool To Study Tissue Distribution and Elimination of NOD in Vitro and in Vivo. Journal of Medicinal Chemistry, 59(21), 9855-9865.
  8. 2015
  9. Gilsbach, B. K., Messias, A. C., Ito, G., Sattler, M., Alessi, D. R., Wittinghofer, A., & Kortholt, A. (2015). Structural Characterization of LRRK2 Inhibitors. Journal of Medicinal Chemistry, 58(9), 3751−3756. https://doi.org/10.1021/jm5018779
  10. Daum, S., Chekhun, V. F., Todor, I. N., Lukianova, N. Y., Shvets, Y. V., Sellner, L., ... Mokhir, A. (2015). Improved Synthesis of N-Benzylaminoferrocene-Based Prodrugs and Evaluation of Their Toxicity and Antileukemic Activity. Journal of Medicinal Chemistry, 58(4), 2015-2024. https://doi.org/10.1021/jm5019548
  11. 2014
  12. 2013
  13. Lease, N., Vasilevski, V., Carreira, M., de Almeida, A., Sanaú, M., Hirva, P., ... Contel, M. (2013). Potential anticancer heterometallic Fe-Au and Fe-Pd agents: Initial mechanistic insights. Journal of Medicinal Chemistry, 56(14), 5806-5818. https://doi.org/10.1021/jm4007615
  14. Abdul-Hay, S. O., Lane, A. L., Caulfield, T. R., Claussin, C., Bertrand, J., Masson, A., ... Leissring, M. A. (2013). Optimization of Peptide Hydroxamate Inhibitors of Insulin-Degrading Enzyme Reveals Marked Substrate-Selectivity. Journal of Medicinal Chemistry, 56(6), 2246-2255. https://doi.org/10.1021/jm301280p
  15. 2012
  16. Schuh, E., Pflueger, C., Citta, A., Folda, A., Rigobello, M. P., Bindoli, A., ... Mohr, F. (2012). Gold(I) Carbene Complexes Causing Thioredoxin 1 and Thioredoxin 2 Oxidation as Potential Anticancer Agents. Journal of Medicinal Chemistry, 55(11), 5518-5528. https://doi.org/10.1021/jm300428v
  17. 2011
  18. Nowak-Sliwinska, P., van Beijnum, J. R., Casini, A., Nazarov, A. A., Wagnieres, G., van den Bergh, H., ... Griffioen, A. W. (2011). Organometallic Ruthenium(II) Arene Compounds with Antiangiogenic Activity. Journal of Medicinal Chemistry, 54(11), 3895-3902. https://doi.org/10.1021/jm2002074
  19. Tetala, K. K. R., Heikema, A. P., Pukin, A. V., Weijers, C. A. G. M., Tio-Gillen, A. P., Gilbert, M., ... van Beek, T. A. (2011). Selective Depletion of Neuropathy-Related Antibodies from Human Serum by Monolithic Affinity Columns Containing Ganglioside Mimics. Journal of Medicinal Chemistry, 54(10), 3500-3505. https://doi.org/10.1021/jm101594s
  20. Mendes, F., Groessl, M., Nazarov, A. A., Tsybin, Y. O., Sava, G., Santos, I., ... Casini, A. (2011). Metal-based inhibition of poly(ADP-ribose) polymerase: The guardian angel of DNA. Journal of Medicinal Chemistry, 54(7), 2196-2206. https://doi.org/10.1021/jm2000135
  21. 2010
  22. 2009
  23. 2008
  24. 2007
  25. 2006
  26. 2005
  27. 2004
  28. Innocenti, A., Casini, A., Alcaro, MC., Papini, AM., Scozzafava, A., & Supuran, CT. (2004). Carbonic anhydrase inhibitors: The first on-resin screening of a 4-sulfamoylphenylthiourea library. Journal of Medicinal Chemistry, 47(21), 5224-5229. https://doi.org/10.1021/jm049692i
  29. Vermeulen, E. S., van Smeden, M., Schmidt, A. W., Sprouse, J. S., Wikström, H. V., & Grol, C. (2004). Novel 5-HT7receptor inverse agonists. Synthesis and molecular modeling of arylpiperazine- and 1,2,3,4-tetrahydroisoquinoline-based arylsulfonamides. Journal of Medicinal Chemistry, 47(22), 5451 - 5466.
  30. 2003
  31. 2002
  32. Venhuis, BJ., Rodenhuis, N., Wikstrom, HV., Wustrow, D., Meltzer, LT., Wise, LD., ... Dijkstra, D. (2002). A new type of prodrug of catecholamines: An opportunity to improve the treatment of Parkinson's disease (vol 45, pg 2349, 2002). Journal of Medicinal Chemistry, 45(18), 4056-4056. [0209634]. https://doi.org/10.1021/jm0209634
Previous 1 2 3 Next

ID: 636490